Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity

Defects of the intracellular enzyme 3′ repair exonuclease 1 (Trex1) cause the rare autoimmune condition Aicardi–Goutières syndrome and are associated with systemic lupus erythematosus. Trex1−/− mice develop type I IFN–driven autoimmunity, resulting from activation of the cytoplasmic DNA sensor cyclic GMP–AMP synthase by a nucleic acid substrate of Trex1 that remains unknown. To identify cell types responsible for initiation of autoimmunity, we generated conditional Trex1 knockout mice. Loss of Trex1 in dendritic cells was sufficient to cause IFN release and autoimmunity, whereas Trex1-deficient keratinocytes and microglia produced IFN but did not induce inflammation. In contrast, B cells, cardiomyocytes, neurons, and astrocytes did not show any detectable response to the inactivation of Trex1. Thus, individual cell types differentially respond to the loss of Trex1, and Trex1 expression in dendritic cells is essential to prevent breakdown of self-tolerance ensuing from aberrant detection of endogenous DNA.

[1]  V. Hornung,et al.  Human plasmacytoid dendritic cells elicit a Type I Interferon response by sensing DNA via the cGAS‐STING signaling pathway , 2016, European journal of immunology.

[2]  Nan Yan,et al.  Cutting Edge: Inhibiting TBK1 by Compound II Ameliorates Autoimmune Disease in Mice , 2015, The Journal of Immunology.

[3]  M. Cancro,et al.  Nucleic Acid–Sensing Receptors: Rheostats of Autoimmunity and Autoinflammation , 2015, The Journal of Immunology.

[4]  Zhijian J. Chen,et al.  Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases , 2015, Proceedings of the National Academy of Sciences.

[5]  Elizabeth E Gray,et al.  Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi–Goutières Syndrome , 2015, The Journal of Immunology.

[6]  Y. Crow,et al.  Aicardi–Goutières syndrome and the type I interferonopathies , 2015, Nature Reviews Immunology.

[7]  Yanbin Zhang,et al.  Human DNA Exonuclease TREX1 Is Also an Exoribonuclease That Acts on Single-stranded RNA* , 2015, The Journal of Biological Chemistry.

[8]  T. Hollis,et al.  Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease , 2015, Proceedings of the National Academy of Sciences.

[9]  A. Bowie,et al.  DNA sensors are expressed in astrocytes and microglia in vitro and are upregulated during gliosis in neurodegenerative disease , 2015, Glia.

[10]  Xiaoming Zhan,et al.  MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses , 2014, Science.

[11]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[12]  G. Barber,et al.  Intrinsic Self-DNA Triggers Inflammatory Disease Dependent on STING , 2014, The Journal of Immunology.

[13]  V. D’Agati,et al.  Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus , 2014, The Journal of experimental medicine.

[14]  Jonathan L. Schmid-Burgk,et al.  TREX1 Deficiency Triggers Cell-Autonomous Immunity in a cGAS-Dependent Manner , 2014, The Journal of Immunology.

[15]  C. Günther,et al.  Deregulated type I IFN response in TREX1-associated familial chilblain lupus. , 2014, The Journal of investigative dermatology.

[16]  C. Johansen,et al.  Inflammatory Cytokines Break Down Intrinsic Immunological Tolerance of Human Primary Keratinocytes to Cytosolic DNA , 2014, The Journal of Immunology.

[17]  A. Celada,et al.  The Exonuclease Trex1 Restrains Macrophage Proinflammatory Activation , 2013, The Journal of Immunology.

[18]  T. Luedde,et al.  A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation , 2013, Nature Neuroscience.

[19]  Zhijian J. Chen,et al.  Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects , 2013, Science.

[20]  J. Rehwinkel,et al.  SAMHD1-dependent retroviral control and escape in mice , 2013, Retrovirology.

[21]  D. Bonthron,et al.  SAMHD1‐dependent retroviral control and escape in mice , 2013, The EMBO journal.

[22]  Werner Müller,et al.  Mouse SAMHD1 Has Antiretroviral Activity and Suppresses a Spontaneous Cell-Intrinsic Antiviral Response , 2013, Cell reports.

[23]  S. Zelenay,et al.  Genetic Tracing via DNGR-1 Expression History Defines Dendritic Cells as a Hematopoietic Lineage , 2013, Cell.

[24]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[25]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[26]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[27]  D. Stetson,et al.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.

[28]  M. Wabl,et al.  An autoimmune disease prevented by anti-retroviral drugs , 2011, Retrovirology.

[29]  M. Christmann,et al.  Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced DNA damage , 2010, Nucleic acids research.

[30]  F. Watt,et al.  Assaying proliferation and differentiation capacity of stem cells using disaggregated adult mouse epidermis , 2010, Nature Protocols.

[31]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[32]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[33]  K. Rajewsky,et al.  Novel Reporter Mouse Reveals Constitutive and Inflammatory Expression of IFN-β In Vivo1 , 2009, The Journal of Immunology.

[34]  G. Barber,et al.  STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling , 2008, Nature.

[35]  T. Heidmann,et al.  Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.

[36]  B. Becher,et al.  Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. , 2008, Immunity.

[37]  S. Pillai,et al.  Peripheral B cell subsets. , 2008, Current opinion in immunology.

[38]  D. Barnes,et al.  Trex1 Exonuclease Degrades ssDNA to Prevent Chronic Checkpoint Activation and Autoimmune Disease , 2007, Cell.

[39]  James B. Mitchell,et al.  Effects of Gamma Radiation on FcεRI and TLR-Mediated Mast Cell Activation1 , 2007, The Journal of Immunology.

[40]  Jos Jonkers,et al.  Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues. , 2007, Physiological genomics.

[41]  J. Lieberman,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus , 2007, Nature Genetics.

[42]  B. Reizis,et al.  Notch–RBP-J signaling controls the homeostasis of CD8− dendritic cells in the spleen , 2007, The Journal of experimental medicine.

[43]  J. Lieberman,et al.  A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus , 2007, Journal of Molecular Medicine.

[44]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[45]  D. Barnes,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.

[46]  R. Braren,et al.  Endothelial FAK is essential for vascular network stability, cell survival, and lamellipodial formation , 2006, The Journal of cell biology.

[47]  D. Barnes,et al.  Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis , 2004, Molecular and Cellular Biology.

[48]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[49]  Dan J. Mazur,et al.  Excision of 3′ Termini by the Trex1 and TREX2 3′→5′ Exonucleases , 2001, The Journal of Biological Chemistry.

[50]  O. Kretz,et al.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety , 1999, Nature Genetics.

[51]  V. Luria,et al.  Maternally expressed PGK-Cre transgene as a tool for early and uniform activation of the Cre site-specific recombinase , 1998, Transgenic Research.

[52]  B. A. French,et al.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. , 1997, The Journal of clinical investigation.

[53]  K. Rajewsky,et al.  B lymphocyte-specific, Cre-mediated mutagenesis in mice. , 1997, Nucleic acids research.

[54]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[55]  U. Ravens,et al.  Alpha adrenoceptor stimulation reduces outward currents in rat ventricular myocytes. , 1989, The Journal of pharmacology and experimental therapeutics.

[56]  K. Hartmann,et al.  Cre/loxP-based mouse models of mast cell deficiency and mast cell-specific gene inactivation. , 2015, Methods in molecular biology.

[57]  Wei Zhang,et al.  Photosensitivity in rheumatic diseases. , 2004, The journal of investigative dermatology. Symposium proceedings.

[58]  K. Rajewsky,et al.  A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. , 1995, Nucleic acids research.

[59]  Excision of 3 * Termini by the Trex1 and TREX2 3 * 3 5 * Exonucleases CHARACTERIZATION OF THE RECOMBINANT PROTEINS* , 2022 .